Trading Statement

Victrex PLC
05 October 2006


Thursday 5 October 2006


                                   Victrex plc


                             ANNUAL TRADING UPDATE


The Company announces its trading update for the year ended 30 September 2006.


Sales volume for the year grew by 19% to approximately 2,338 tonnes (2005: 1,972
tonnes). Second half sales volume of around 1,225 tonnes increased by 10%
compared with 1,113 tonnes for the first half.


   •Second half European sales volume increased by 15% to 639 tonnes compared
    with the first half (556 tonnes). Accordingly, full year sales volume of
    1,195 tonnes was 23% up on last year (969 tonnes).
   •United States second half sales volume was 376 tonnes, up 8% on the
    strong first half (348 tonnes). As a result, full year sales volume of 724
    tonnes was up 19% on the previous year (608 tonnes).
   •Second half Asia-Pacific sales volume of 210 tonnes matched the first
    half performance of 209 tonnes. Annual sales volume of 419 tonnes for the
    year was up 6% on 2005 (395 tonnes).
   •Invibio, our biomaterials business, continued to perform well with second
    half revenue in line with the first half performance of £7.6m.



Overall, we expect profits for the year to be in line with analysts'
expectations.


Looking ahead to 2007, trading results will be impacted by the further
strengthening of Sterling against our key trading currencies (Euro, Dollar and
Yen) since our interim announcement in June. However, we remain confident in the
underlying growth potential for the business.


The preliminary announcement of the Company's results for the year ended 30
September 2006 will be made on Tuesday 5 December 2006.


                                    - Ends -


For further information please contact:

Victrex plc                                              01253 897700
Michael Peacock, Finance Director
Hogarth Partnership Limited                              0207 357 9477
Nick Denton / Barnaby Fry


VICTREX PLC is an innovative, world leader in high performance materials through
the manufacture of VICTREX(R) PEEK polymer, a high performance, easy to
process, thermoplastic.


VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis
and temperature resistance, as well as excellent dimensional, mechanical and
chemical stability combined with inherent purity and low flammability.


End users specify VICTREX PEEK to reduce systems costs, improve part
performance, exploit greater design freedom and create a differentiated
application. VICTREX PEEK is used across a broad range of applications in
diverse markets including transport, industrial, electronics and medical.
Invibio(R), Victrex's biomaterial business, provides specialised solutions for
medical device manufacturers.




                      This information is provided by RNS
            The company news service from the London Stock Exchange